Gender characteristics of gout and differences in response to taking xanthioxidase inhibitors

Introduction. To date, there is no consensus regarding the gender characteristics of the course of gout. There is little data on the possible difference between men and women in response to uric acid-lowering therapy.Aim. To compare the clinical characteristics of the course of gout and evaluate the...

Full description

Bibliographic Details
Main Authors: V. V. Tsurko, M. A. Gromova
Format: Article
Language:Russian
Published: Remedium Group LLC 2021-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/6545
_version_ 1827962042397491200
author V. V. Tsurko
M. A. Gromova
author_facet V. V. Tsurko
M. A. Gromova
author_sort V. V. Tsurko
collection DOAJ
description Introduction. To date, there is no consensus regarding the gender characteristics of the course of gout. There is little data on the possible difference between men and women in response to uric acid-lowering therapy.Aim. To compare the clinical characteristics of the course of gout and evaluate the differences in response to urate-lowering therapy (ULT) with allopurinol and febuxostat in men and women.Material and methods. The retrospective cohort study included 279 men and 83 women diagnosed with gout (ACR/EULAR, 2015). The comparative analysis of the clinical characteristics of gout, as well as responses to the intake of xanthioxidase (XO) inhibitors in representatives of different sexes, was carried out. We compared the gender characteristics of obtaining a positive response to ULT, defined as achieving a target serum uric acid (sUA) level of < 360 μmol / l within 6 months of treatment, while taking allopurinol and febuxostat.Results. By the age at which the onset of gout took place, women were older than men, the duration of the disease in them was shorter. Men showed a shorter duration of the first attack of arthritis. Chronic arthritis was diagnosed in 56% of men and 35% of women (p < 0.05). The process involved the joints of both the lower and upper extremities. However, more often the joints of the lower extremities were affected in men, and in the upper extremities in women. Tophus were detected in 35% of patients, of whom 30.3% were men, 4.7% were women (p < 0.05). Allopurinol was prescribed to 216 men and 54 women, and febuxostat was prescribed to 63 men and 29 women. After six months, the proportion of women who achieved the target sUA was 57.5% and 65.8%, the proportion of men – 60.4% and 76.2% for allopurinol and febuxostat, respectively.Conclusion. The clinical manifestations of gout in men and women differ. Due to the pronounced increase in the level of uric acid, men develop more severe joint damage due to the tendency to chronicity. However, the study did not reveal gender differences in the response to XO inhibitors, which indicates that there is no need to choose therapy depending on the patient’s gender.
first_indexed 2024-04-09T16:36:09Z
format Article
id doaj.art-08773925b8744e69b98bb7d81d96b1fa
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:36:09Z
publishDate 2021-12-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-08773925b8744e69b98bb7d81d96b1fa2023-04-23T06:56:53ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902021-12-0101916416910.21518/2079-701X-2021-19-164-1695908Gender characteristics of gout and differences in response to taking xanthioxidase inhibitorsV. V. Tsurko0M. A. Gromova1Pirogov Russian National Research Medical University; Sechenov First Moscow State Medical University (Sechenov University)Pirogov Russian National Research Medical UniversityIntroduction. To date, there is no consensus regarding the gender characteristics of the course of gout. There is little data on the possible difference between men and women in response to uric acid-lowering therapy.Aim. To compare the clinical characteristics of the course of gout and evaluate the differences in response to urate-lowering therapy (ULT) with allopurinol and febuxostat in men and women.Material and methods. The retrospective cohort study included 279 men and 83 women diagnosed with gout (ACR/EULAR, 2015). The comparative analysis of the clinical characteristics of gout, as well as responses to the intake of xanthioxidase (XO) inhibitors in representatives of different sexes, was carried out. We compared the gender characteristics of obtaining a positive response to ULT, defined as achieving a target serum uric acid (sUA) level of < 360 μmol / l within 6 months of treatment, while taking allopurinol and febuxostat.Results. By the age at which the onset of gout took place, women were older than men, the duration of the disease in them was shorter. Men showed a shorter duration of the first attack of arthritis. Chronic arthritis was diagnosed in 56% of men and 35% of women (p < 0.05). The process involved the joints of both the lower and upper extremities. However, more often the joints of the lower extremities were affected in men, and in the upper extremities in women. Tophus were detected in 35% of patients, of whom 30.3% were men, 4.7% were women (p < 0.05). Allopurinol was prescribed to 216 men and 54 women, and febuxostat was prescribed to 63 men and 29 women. After six months, the proportion of women who achieved the target sUA was 57.5% and 65.8%, the proportion of men – 60.4% and 76.2% for allopurinol and febuxostat, respectively.Conclusion. The clinical manifestations of gout in men and women differ. Due to the pronounced increase in the level of uric acid, men develop more severe joint damage due to the tendency to chronicity. However, the study did not reveal gender differences in the response to XO inhibitors, which indicates that there is no need to choose therapy depending on the patient’s gender.https://www.med-sovet.pro/jour/article/view/6545goutmenwomenarthritistophusurate-lowering therapyallopurinolfebuxostat
spellingShingle V. V. Tsurko
M. A. Gromova
Gender characteristics of gout and differences in response to taking xanthioxidase inhibitors
Медицинский совет
gout
men
women
arthritis
tophus
urate-lowering therapy
allopurinol
febuxostat
title Gender characteristics of gout and differences in response to taking xanthioxidase inhibitors
title_full Gender characteristics of gout and differences in response to taking xanthioxidase inhibitors
title_fullStr Gender characteristics of gout and differences in response to taking xanthioxidase inhibitors
title_full_unstemmed Gender characteristics of gout and differences in response to taking xanthioxidase inhibitors
title_short Gender characteristics of gout and differences in response to taking xanthioxidase inhibitors
title_sort gender characteristics of gout and differences in response to taking xanthioxidase inhibitors
topic gout
men
women
arthritis
tophus
urate-lowering therapy
allopurinol
febuxostat
url https://www.med-sovet.pro/jour/article/view/6545
work_keys_str_mv AT vvtsurko gendercharacteristicsofgoutanddifferencesinresponsetotakingxanthioxidaseinhibitors
AT magromova gendercharacteristicsofgoutanddifferencesinresponsetotakingxanthioxidaseinhibitors